Evidence map›Paper›PMID 32811636›Full record

ArticleJournal of substance abuse treatment2020

On providing smoking cessation services in alcohol and other drug treatment settings: Results from a U.S. national survey of attitudes among recovering persons.

John F Kelly, M Claire Greene, Lauren A Hoffman, Bettina B Hoeppner, Brandon G Bergman

Open access · greenAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

John F KellyRecovery Research Institute, Massachusetts General Hospital, Harvard Medical School, 151 Merrimac Street, Boston, MA 02114, United States of America. Electronic address: jkelly11@mgh.harvard.edu.
M Claire GreeneDepartment of Psychiatry, Columbia University & New York State Psychiatric Institute, New York, NY, United States of America.
Lauren A HoffmanRecovery Research Institute, Massachusetts General Hospital, Harvard Medical School, 151 Merrimac Street, Boston, MA 02114, United States of America.
Bettina B HoeppnerRecovery Research Institute, Massachusetts General Hospital, Harvard Medical School, 151 Merrimac Street, Boston, MA 02114, United States of America.
Brandon G BergmanRecovery Research Institute, Massachusetts General Hospital, Harvard Medical School, 151 Merrimac Street, Boston, MA 02114, United States of America.
Harvard University · USMassachusetts General Hospital · USNew York State Psychiatric Institute

Funding

Global Mental Health Research Fellowship: Interventions That Make a DifferenceT32MH096724 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILTON L WAINBERG · 2012 to 2026
$4.4M
Mentoring in Patient-Oriented Addiction ResearchK24AA022136 · NIAAA · MASSACHUSETTS GENERAL HOSPITAL · PI KELLY, JOHN F. · 2014 to 2023
$1.8M
Funded extension request for "Expanding recovery support for emerging adults with alcohol use disorder: Training in the science of social network sites"K23AA025707 · NIAAA · MASSACHUSETTS GENERAL HOSPITAL · PI BERGMAN, BRANDON G. · 2018 to 2023
$1.0M
Opioid use disorder, cognition, and recovery: An investigation of neuropsychological change and associated recovery outcomes in buprenorphine and methadone treated patients [SUPPLEMENT]F32DA047741 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI HOFFMAN, LAUREN A · 2019 to 2022
$224k
NIAAA NIH HHS K23 AA025707NIAAA NIH HHS K24 AA022136NIDA NIH HHS F32 DA047741NIMH NIH HHS T32 MH096724
6 · The paper itself

Abstract

backgroundNicotine addiction through cigarette use is highly prevalent among individuals suffering from alcohol and other drug (AOD) problems and remains a prominent risk factor for morbidity, mortality, and healthcare utilization. Whereas most people agree that providing smoking cessation services (SCS) to this vulnerable population is vitally important, the timing of such service provision has been hotly debated, including whether such services should be excluded, available (but not offered), offered, or fully integrated into AOD treatment settings. Important stakeholders in this debate are those in recovery from AOD problems who, in addition to having often been AOD treatment patients themselves, frequently hold influential clinical, research or policy positions and thus can influence the likelihood of SCS provision. This study sought to understand the attitudes of this important stakeholder group in providing SCS in AOD treatment settings.

methodWe assessed a national cross-sectional sample of individuals in recovery from an AOD problem (n = 1973) on whether SCS should be: a. excluded; b. available; c. offered; or d. integrated into AOD services. We estimated associations between participants' demographic, clinical, and recovery support service use history, and SCS attitude variables, using multinomial logistic regression.

resultsRoughly equal proportions endorsed each attitudinal position (23.5% excluded, 25% available, 24.6% offered; 26.9% integrated). Correlates of holding more positive SCS implementation attitudes were Black race; primary substance other than alcohol, greater intensity of former or recent smoking, and less mutual-help organization participation; older individuals achieving recovery between 30 and 40 years ago also had more positive attitudes toward integrating SCS.

conclusionsAbout half of those sampled were either against SCS inclusion in AOD settings or were in favor of making it "available" only, but not in offering it or integrating it. This oppositional pattern was accentuated particularly among those with primary alcohol problem histories and those participating in mutual-help organizations. Given the universally well-known negative health effects of smoking, understanding more about the exact reasons why certain groups of recovering persons may endorse such positions is an area worthy of further investigation, as it may uncover potential barriers to SCS implementation in AOD treatment settings.

Indexed as

Pharmaceutical PreparationsSmoking CessationSubstance-Related DisordersAttitudeCross-Sectional StudiesHumansPatient Acceptance of Health CareSmokingPharmaceutical PreparationsAddictionCigarette smokingEpidemiologyNationalRecoveryRemissionSmoking cessation services in addiction treatmentSubstance use disorder treatment

Identifiers

PMID32811636
PMCPMC7556344
OpenAlexW3035440617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.